Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Non-Current Liabilities ₹2,681 Cr₹1,270 Cr₹2,804 Cr₹3,033 Cr₹2,280 Cr

What is the latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹2,681 Cr based on Mar2023 Consolidated results.
Year Total Non-Current Liabilities
Mar2023₹2,681 Cr
Mar2022₹1,270 Cr
Mar2021₹2,804 Cr
Mar2020₹3,033 Cr
Mar2019₹2,280 Cr

How is Total Non-Current Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2023 ₹2,681 Cr
111.16
Mar2022 ₹1,270 Cr
-54.72
Mar2021 ₹2,804 Cr
-7.56
Mar2020 ₹3,033 Cr
33.03
Mar2019 ₹2,280 Cr -

Compare Total Non-Current Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹29,743.9 Cr -2.4% 7.4% 88% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.4%

7.4%

88%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses